page_banner

product

Calcitonin (salmon)(CAS#47931-85-1)

Chemical Property:

Molecular Formula C145H240N44O48S2
Molar Mass 3431.85
Density 1.54±0.1 g/cm3(Predicted)
Melting Point >222oC (dec.)
Water Solubility Soluble in water at 1mg/ml
Solubility 0.05 M acetic acid: 1mg/mL, clear, colorless
Appearance powder
Color White to Off-White
Merck 13,1642
Storage Condition −20°C
Refractive Index 1.676
MDL MFCD00133859
Use Hypocalcetin (Hypocalcemic hormone) is produced by the parafollicular C cells or by the gills of invertebrates (nonmammalian vertebrates). The decrease of calcium and phosphorus in blood inhibits the absorption of osteoblasts (osteoblasts) and osteocytes cells.

Product Detail

Product Tags

Safety Description S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
WGK Germany 3
RTECS EV8000000
FLUKA BRAND F CODES 3-10
HS Code 2937190000

 

 

Calcitonin (salmon)(CAS#47931-85-1)

Salmon calcitonin nasal spray
【Ingredients】

The main ingredient of this product is the synthesis of calcium, and its chemical name is as follows:

(1,7-disulfidecyclo) half cystyl-seryl-asparagine-leucyl-seryl-threonyl-cysteinyl-valyl-leucyl-glycyl

Lysyl-leucyl-seryl-glutaminyl-glutamyl-glutamyl-leucyl-histamine-lysyl-leucyl-glutaminoyl-threonyl-tyrosyl-prolyl-arginamino-threonyl-asparagine-threonyl-threonyl-seryl-glycyl-threonyl-threonyl-proline-threonyl-proline

Molecular Weight: 3431.89

【Properties】The contents of this product are colorless or almost colorless clear liquid.

【Seating Disorder】

1. Osteoporosis:

early and late postmenopausal osteoporosis;
Senile osteoporosis:
Secondary osteoporosis, e.g., corticosteroid therapy or inactivity. To prevent progressive bone loss, calcium and vitamin D should be consumed in moderate amounts according to the individual’s needs.
2. Bone pain with osteolysis and/or osteopenia.

3. Paget’s disease (degenerative osteitis), especially in patients with the following conditions:

Ostealgia:
neurological complications;
increased bone turnover, as evidenced by increased serum alkaline phosphatase and urinary hydroxyproline excretion;
Progressive spread of bone lesions:
Incomplete or recurrent fractures.
4. Hypercalcemia and hypercalcemia caused by:

neoplastic osteolysis of secondary breast, lung or kidney cancer, myeloma, and other malignant diseases;
hyperparathyroidism, lack of activity, or vitamin D toxicity;
emergency treatment of hypercalcemia crisis; Chronic hypercalcemia requires long-term treatment and should be continued until specific treatment for the underlying disorder is effective;
5. Neurodystrophy (painful neurodystrophy or Sudeck’s disease): caused by different causes and triggers, such as post-traumatic osteoporosis, sympathetic dystrophy, shoulder-arm syndrome, burning pain due to peripheral nerve injury, drug-induced neurodystrophy.


  • Previous:
  • Next:

  • Write your message here and send it to us